HIGHLAND CAPITAL MANAGEMENT LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 270 filers reported holding NEKTAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2018$223,000
-14.2%
2,100
-51.7%
0.01%
-8.3%
Q4 2017$260,000
-5.8%
4,350
-62.2%
0.01%0.0%
Q3 2017$276,000
-43.6%
11,500
-54.0%
0.01%
-42.9%
Q2 2017$489,000
-16.7%
25,0000.0%0.02%
-30.0%
Q1 2017$587,000
-52.2%
25,000
-75.0%
0.03%
-48.3%
Q4 2016$1,227,000100,0000.06%
Q3 2013$000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders